Gynae Centre Ltd - Accounts to registrar (filleted)

REGISTERED NUMBER: 03542527 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

FOR

GYNAE CENTRE LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Dr A A Eskander

SECRETARY:

Mrs S Eskander

REGISTERED OFFICE:

10 London Mews

London

LONDON

W2 1HY

REGISTERED NUMBER:

03542527 (England and Wales)

ACCOUNTANTS:

Stein Richards

Chartered Accountants

10 London Mews

London

W21HY

FIXED ASSETS

Tangible assets

4

754,892

CURRENT ASSETS

Debtors

5

302,568

284,740

Cash at bank and in hand

367,843

839,840

670,411

1,124,580

CREDITORS

Amounts falling due within one year

6

454,641

566,007

NET CURRENT ASSETS

215,770

558,573

TOTAL ASSETS LESS CURRENT
LIABILITIES

970,662

1,313,465

CAPITAL AND RESERVES

Called up share capital

7

100

Retained earnings

970,562

1,313,365

SHAREHOLDERS' FUNDS

970,662

1,313,465

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 March 2026 and were signed by:

Dr A A Eskander - Director

1.	STATUTORY INFORMATION

Gynae Centre Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern

After reviewing the company's forecasts and projections, the directors have reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Turnover

Turnover represents invoiced medical treatment in the year, net of discounts.

Rendering of services

Revenue for providing services is recognised in the period when medical appointments are completed.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Short leasehold

-

Per Frsse 2015, no depreciation provided

Fixtures and fittings

-

25% straight line

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other debtors and creditors and loans to related parties.

The basic financial debtors and liabilities as listed above are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future payments / receipts discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment. An impairment review is undertaken annually at the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2024 - 5 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Short

and

Motor

leasehold

fittings

vehicles

Totals

£

COST

At 1 July 2024

and 30 June 2025

754,890

210,087

86,500

1,051,477

DEPRECIATION

At 1 July 2024

and 30 June 2025

-

210,086

86,499

296,585

NET BOOK VALUE

At 30 June 2025

754,890

1

754,892

At 30 June 2024

754,890

1

754,892

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

Other debtors

302,568

284,740

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

Trade creditors

22,529

14,828

Taxation and social security

111

104,748

Other creditors

432,001

446,431

454,641

566,007

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.25

30.6.24

value:

£

100

Ordinary

1

100